Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The levels and conformers of alpha-synuclein are critical in the pathogenesis of Parkinson's Disease and related synucleinopathies. Homeostatic mechanisms in protein degradation and secretion have been identified as regulators of alpha-synuclein at different stages of its intracellular trafficking and transcellular propagation. Here we review pathways involved in the removal of various forms of alpha-synuclein from both the intracellular and extracellular environment. Proteasomes and lysosomes are likely to play complementary roles in the removal of intracellular alpha-synuclein species, in a manner that depends on alpha-synuclein post-translational modifications. Extracellular alpha-synuclein is cleared by extracellular proteolytic enzymes, or taken up by neighboring cells, especially microglia and astrocytes, and degraded within lysosomes. Exosomes, on the other hand, represent a vehicle for egress of excess burden of the intracellular protein, potentially contributing to the transfer of alpha-synuclein between cells. Dysfunction in any one of these clearance mechanisms, or a combination thereof, may be involved in the initiation or progression of Parkinson's disease, whereas targeting these pathways may offer an opportunity for therapeutic intervention. This article is part of the Special Issue "Synuclein".

Original publication

DOI

10.1111/jnc.14704

Type

Journal article

Journal

J Neurochem

Publication Date

09/2019

Volume

150

Pages

577 - 590

Keywords

alpha-synuclein, degradation, exosomes, lysosomes, proteasome, ubiquitin, Astrocytes, Disease Progression, Exosomes, Extracellular Fluid, Genetic Therapy, Humans, Immunotherapy, Intracellular Fluid, Lewy Bodies, Lysosomes, Microglia, Parkinson Disease, Phosphorylation, Proteasome Endopeptidase Complex, Protein Aggregation, Pathological, Protein Processing, Post-Translational, Proteolysis, Ubiquitination, alpha-Synuclein